Chi‐Feng Chang

1.3k total citations
13 papers, 477 citations indexed

About

Chi‐Feng Chang is a scholar working on Molecular Biology, Otorhinolaryngology and Epidemiology. According to data from OpenAlex, Chi‐Feng Chang has authored 13 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Otorhinolaryngology and 4 papers in Epidemiology. Recurrent topics in Chi‐Feng Chang's work include Cervical Cancer and HPV Research (4 papers), Head and Neck Cancer Studies (4 papers) and Epigenetics and DNA Methylation (3 papers). Chi‐Feng Chang is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Head and Neck Cancer Studies (4 papers) and Epigenetics and DNA Methylation (3 papers). Chi‐Feng Chang collaborates with scholars based in Taiwan, United States and Italy. Chi‐Feng Chang's co-authors include Huei‐Jen Wang, Adrian Parr, Kitty A. Plaskitt, Yu‐Ligh Liou, Ángel Mérida, Nicola Stacey, Cathie Martin, Keith Roberts, J. Maxwell Dow and David G. Lynn and has published in prestigious journals such as The Plant Cell, Gynecologic Oncology and Alzheimer s & Dementia.

In The Last Decade

Chi‐Feng Chang

13 papers receiving 463 citations

Peers

Chi‐Feng Chang
Bing Zhou China
Chi‐Feng Chang
Citations per year, relative to Chi‐Feng Chang Chi‐Feng Chang (= 1×) peers Bing Zhou

Countries citing papers authored by Chi‐Feng Chang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Feng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Feng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Feng Chang more than expected).

Fields of papers citing papers by Chi‐Feng Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Feng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Feng Chang. The network helps show where Chi‐Feng Chang may publish in the future.

Co-authorship network of co-authors of Chi‐Feng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Feng Chang. A scholar is included among the top collaborators of Chi‐Feng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Feng Chang. Chi‐Feng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chang, Chih-Long, et al.. (2021). DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan. Gynecologic Oncology. 161(2). 429–435. 33 indexed citations
2.
Jeong, Sohyun, Li‐Kai Huang, Ming‐Ju Tsai, et al.. (2021). Whole genome shotgun metagenomic sequencing to identify differential abundant microbiome features between dementia and mild cognitive impairment (MCI) in AD subjects. Alzheimer s & Dementia. 17(S5). 2 indexed citations
3.
Yang, Cheng‐Chieh, et al.. (2018). DNA methylation confers clinical potential to predict the oral cancer prognosis. 4(5). 5 indexed citations
5.
Cheng, Shih‐Jung, Chi‐Feng Chang, Hui‐Hsin Ko, et al.. (2017). Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection. Head & Neck. 40(2). 355–368. 40 indexed citations
6.
Liou, Yu‐Ligh, Tao‐Lan Zhang, Yan Tian, et al.. (2016). Combined clinical and genetic testing algorithm for cervical cancer diagnosis. Clinical Epigenetics. 8(1). 66–66. 37 indexed citations
7.
Cheng, Shih‐Jung, Chi‐Feng Chang, Jang‐Jaer Lee, et al.. (2016). Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer. Oral Oncology. 62. 34–43. 43 indexed citations
8.
Liou, Yu‐Ligh, Yu Zhang, Yingzi Liu, et al.. (2015). Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results. Clinical Epigenetics. 7(1). 50–50. 29 indexed citations
9.
Liou, Yu‐Ligh, et al.. (2014). PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening. International Journal of Gynecological Cancer. 24(5). 928–934. 62 indexed citations
10.
11.
Lee, Ming Ta Michael, Chien-Hsiun Chen, Hui-Ping Chuang, et al.. (2009). VKORC1 Haplotypes in Five East-Asian Populations and Indians. Pharmacogenomics. 10(10). 1609–1616. 14 indexed citations
12.
Mérida, Ángel, Nicola Stacey, Kitty A. Plaskitt, et al.. (1998). Inhibition of Phenolic Acid Metabolism Results in Precocious Cell Death and Altered Cell Morphology in Leaves of Transgenic Tobacco Plants. The Plant Cell. 10(11). 1801–1801. 13 indexed citations
13.
Mérida, Ángel, Nicola Stacey, Kitty A. Plaskitt, et al.. (1998). Inhibition of Phenolic Acid Metabolism Results in Precocious Cell Death and Altered Cell Morphology in Leaves of Transgenic Tobacco Plants. The Plant Cell. 10(11). 1801–1816. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026